Tag: Facility
Catalent continues big push into cell and gene therapies with Belgian...
New Jersey CDMO Catalent has made waves the past couple years in the bustling cell and gene therapy space with a series of big...
Merck, plagued by limited supply of bladder cancer drug, will build...
During its years as sole producer of a difficult-to-make cancer med in high demand, Merck & Co.'s limited capacity has hamstrung its efforts to...
Tennessee packaging company drops $21M into ‘state-of-the-art’ facility for push into...
With the demand for American-made drugs high, companies up and down the supply chain are dropping major down payments to keep up. Tennessee's Aphena...
Biotech that bought GSK’s ‘bubble boy’ drug to build stem cell...
Another cell manufacturing facility will be built in the U.S., this one by a transatlantic biotech in which GlaxoSmithKline owns a sizable share.
The U.K.-based...
